These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38782201)

  • 1. Liraglutide's Effect on Weight Management in Subjects With Pre-diabetes: A Systematic Review & Meta-Analysis.
    Alsanea S; Alkofide H; Almadi B; Almohammed O; Alwhaibi A; Alrabiah Z; Kalagi N
    Endocr Pract; 2024 Aug; 30(8):737-745. PubMed ID: 38782201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis.
    Zhang P; Liu Y; Ren Y; Bai J; Zhang G; Cui Y
    Afr Health Sci; 2019 Sep; 19(3):2591-2599. PubMed ID: 32127832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials.
    Austregésilo de Athayde De Hollanda Morais B; Martins Prizão V; de Moura de Souza M; Ximenes Mendes B; Rodrigues Defante ML; Cosendey Martins O; Rodrigues AM
    J Diabetes Complications; 2024 Oct; 38(10):108834. PubMed ID: 39178623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide 3.0 mg (Saxenda©) for Weight Loss and Remission of Pre-Diabetes. Real-World Clinical Evaluation of Effectiveness among Patients Awaiting Bariatric Surgery.
    Wilmington R; Ardavani A; Simenacz A; Green C; Idris I
    Obes Surg; 2024 Jan; 34(1):286-289. PubMed ID: 38012508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological and non-pharmacological strategies for obese women with subfertility.
    Taghavi SA; van Wely M; Jahanfar S; Bazarganipour F
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012650. PubMed ID: 33765343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials.
    Ard J; Cannon A; Lewis CE; Lofton H; Vang Skjøth T; Stevenin B; Pi-Sunyer X
    Diabetes Obes Metab; 2016 Apr; 18(4):430-5. PubMed ID: 26744025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trials.
    von Scholten BJ; Davies MJ; Persson F; Hansen TW; Madsbad S; Endahl L; Jepsen CH; Rossing P
    J Diabetes Complications; 2017 Jul; 31(7):1164-1168. PubMed ID: 28462892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effectiveness and safety of liraglutide in clinical practice.
    Ponzani P
    Minerva Endocrinol; 2013 Mar; 38(1):103-12. PubMed ID: 23435446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial.
    Blackman A; Foster GD; Zammit G; Rosenberg R; Aronne L; Wadden T; Claudius B; Jensen CB; Mignot E
    Int J Obes (Lond); 2016 Aug; 40(8):1310-9. PubMed ID: 27005405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes.
    Santilli F; Simeone PG; Guagnano MT; Leo M; Maccarone MT; Di Castelnuovo A; Sborgia C; Bonadonna RC; Angelucci E; Federico V; Cianfarani S; Manzoli L; Davì G; Tartaro A; Consoli A
    Diabetes Care; 2017 Nov; 40(11):1556-1564. PubMed ID: 28912305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.
    Dejgaard TF; Frandsen CS; Hansen TS; Almdal T; Urhammer S; Pedersen-Bjergaard U; Jensen T; Jensen AK; Holst JJ; Tarnow L; Knop FK; Madsbad S; Andersen HU
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):221-232. PubMed ID: 26656289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide reduces the body weight and waist circumference in Chinese overweight and obese type 2 diabetic patients.
    Feng P; Yu DM; Chen LM; Chang BC; Ji QD; Li SY; Zhu M; Ding SH; Zhang BZ; Wang SL; Li HT; Lin JN; Wang MJ; Guo JC; Liu J; Liu ZD; Wu ST; Yang JH
    Acta Pharmacol Sin; 2015 Feb; 36(2):200-8. PubMed ID: 25619391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide: A Glucagon-Like Peptide-1 Agonist for Chronic Weight Management.
    Manigault KR; Thurston MM
    Consult Pharm; 2016 Dec; 31(12):685-697. PubMed ID: 28074747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily liraglutide (1.2 mg) compared with twice-daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta-analysis.
    Twigg SM; Daja MM; O'leary BA; Adena MA
    J Diabetes; 2016 Nov; 8(6):866-876. PubMed ID: 26729046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of liraglutide for weight management in children and adolescents: a systematic review and meta-analysis of randomized controlled trials.
    Gou H; Zhai Y; Guo J
    Eur J Pediatr; 2023 Nov; 182(11):5095-5108. PubMed ID: 37672063
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.